Ribose
Star0
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Explore a selection of our essential drug information below, or:
Identification
- Generic Name
- Ribose
- DrugBank Accession Number
- DB15073
- Background
Ribose is under investigation in clinical trial NCT01727479 (Ribose and Sport Performance).
- Type
- Small Molecule
- Groups
- Investigational
- Structure
- Weight
- Average: 150.1299
Monoisotopic: 150.05282343 - Chemical Formula
- C5H10O5
- Synonyms
- aldehydo-D-ribose
- D-ribo-2,3,4,5-tetrahydroxyvaleraldehyde
- D-Ribose
- Ribose
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 681HV46001
- CAS number
- 50-69-1
- InChI Key
- PYMYPHUHKUWMLA-LMVFSUKVSA-N
- InChI
- InChI=1S/C5H10O5/c6-1-3(8)5(10)4(9)2-7/h1,3-5,7-10H,2H2/t3-,4+,5-/m0/s1
- IUPAC Name
- (2R,3R,4R)-2,3,4,5-tetrahydroxypentanal
- SMILES
- [H]C(=O)[C@H](O)[C@H](O)[C@H](O)CO
References
Clinical Trials
- Clinical Trials
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package Phase Status Purpose Conditions Count Start Date Why Stopped 100+ additional columns Unlock 175K+ rows when you subscribe.View sample dataNot Available Terminated Not Available Congestive Heart Failure (CHF) 1 somestatus stop reason just information to hide 2 Completed Treatment 5'-Nucleotidase Syndrome 1 somestatus stop reason just information to hide 2 Completed Treatment Fibromyalgia 1 somestatus stop reason just information to hide 2 Completed Treatment Heart Failure, Diastolic 1 somestatus stop reason just information to hide 2 Not Yet Recruiting Treatment Fallopian Tube Cancer / High Grade Endometrioid Ovarian Cancer / High Grade Serous Adenocarcinoma of Ovary / Ovarian Cancer / Primary Peritoneal Cancer 1 somestatus stop reason just information to hide
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 380.0 mg/mL ALOGPS logP -2.3 ALOGPS logP -2.9 Chemaxon logS 0.4 ALOGPS pKa (Strongest Acidic) 12.34 Chemaxon pKa (Strongest Basic) -3 Chemaxon Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 5 Chemaxon Hydrogen Donor Count 4 Chemaxon Polar Surface Area 97.99 Å2 Chemaxon Rotatable Bond Count 4 Chemaxon Refractivity 31.38 m3·mol-1 Chemaxon Polarizability 13.39 Å3 Chemaxon Number of Rings 0 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter No Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Chromatographic Properties
Collision Cross Sections (CCS)
Adduct CCS Value (Å2) Source type Source [M-H]- 128.9347907 predictedDarkChem Lite v0.1.0 [M-H]- 129.0263907 predictedDarkChem Lite v0.1.0 [M-H]- 130.02922 predictedDeepCCS 1.0 (2019) [M+H]+ 130.2741907 predictedDarkChem Lite v0.1.0 [M+H]+ 131.1734907 predictedDarkChem Lite v0.1.0 [M+H]+ 132.40216 predictedDeepCCS 1.0 (2019) [M+Na]+ 128.9681907 predictedDarkChem Lite v0.1.0 [M+Na]+ 129.0103907 predictedDarkChem Lite v0.1.0 [M+Na]+ 138.75218 predictedDeepCCS 1.0 (2019)
Drug created at May 20, 2019 14:47 / Updated at June 12, 2020 16:53